{
  "url": "https://openlegislation.uk/eu-regulation-2006-816/article-9",
  "json_url": "https://openlegislation.uk/eu-regulation-2006-816/article-9.json",
  "legislation": "eur/2006/816",
  "legislation_title": "Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2006-816",
  "path": "article/9",
  "kind": "article",
  "number": "9",
  "heading": "Prior negotiation",
  "text": "1. The applicant shall provide evidence to satisfy the competent authority that he has made efforts to obtain authorisation from the rights-holder and that such efforts have not been successful within a period of thirty days before submitting the application.\n2. The requirement in paragraph 1 shall not apply in situations of national emergency or other circumstances of extreme urgency or in cases of public non-commercial use under Article 31(b) of the TRIPS Agreement.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2006/816/article/9",
    "retrieved_at": "2026-11-01T14:53:42.913678+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}